VšĮ Infekcinių ligų ir patogeninės mikrobiologijos institutas Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
93,436 |
23,359 |
0 |
- |
- |
0.47 |
0.01 |
- |
- |
33,721 |
407 |
6,369 |
44,188 |
2022 |
---|
144,953 |
40,603 |
0 |
- |
- |
0.30 |
0.11 |
- |
- |
51,125 |
5,409 |
6,924 |
49,610 |
2023 |
---|
104,192 |
34,731 |
0 |
- |
- |
0.29 |
0.11 |
- |
- |
50,555 |
5,346 |
20,014 |
35,887 |
Register and
explore Okredo data2023 |
---|
104,192 |
34,731 |
0 |
- |
- |
0.29 |
0.11 |
- |
- |
50,555 |
5,346 |
20,014 |
35,887 |
Register and
explore Okredo data2023
Turnover (€)
104,192 €-28 % *
Sales per employee (€)
34,731 €-14 % *
Profit before tax (€)
0 €- *
Net Profit (€)
-Profit per employee (€)
-Working capital requirement
0.29 -3.33 % *
Debt-to-equity ratio
0.11 0.00 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
50,555 €-1 % *
Amounts Payable And Liabilities (€)
5,346 €-1 % *
Non-current Assets (€)
20,014 €189 % *
CurrentAssets (€)
35,887 €-28 % *